Cubist Systematic Strategies’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,900
Closed -$516K 3544
2024
Q3
$516K Buy
13,900
+6,800
+96% +$254K ﹤0.01% 2193
2024
Q2
$338K Sell
7,100
-23,500
-77% -$1.03M ﹤0.01% 2297
2024
Q1
$1.17M Sell
30,600
-13,300
-30% -$432K 0.01% 2040
2023
Q4
$1.37M Buy
43,900
+18,400
+72% +$661K 0.01% 1809
2023
Q3
$1.02M Buy
25,500
+18,200
+249% +$852K 0.01% 1869
2023
Q2
$384K Buy
7,300
+1,900
+35% +$116K ﹤0.01% 2525
2023
Q1
$345K Buy
+5,400
New +$352K ﹤0.01% 2896

Other funds holding STAA

Cubist Systematic Strategies's STAA Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of STAAR Surgical (STAA) in Q1 2024, closing a stake of 106,731 shares — an estimated $3.47M sold.

Cubist Systematic Strategies first reported a position in STAA in Q2 2018 and held it in 17 quarters. The position peaked at $10.3M in Q4 2022. 198 funds tracked by Wall St. Rank hold STAA as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining STAAR Surgical position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 106,731 STAAR Surgical shares in Q1 2024, an estimated $3.47M.
  • Cubist Systematic Strategies first reported a position in STAAR Surgical in Q2 2018 and held it in 17 quarters.
  • Cubist Systematic Strategies's STAAR Surgical position peaked at $10.3M in Q4 2022.
  • 198 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.